Contract research and service companies at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

70 contract research and service companies are at SfN 2026 — 113 presentations on the program and 40 with a booth in the exhibit hall. Most represented: Suven Life Sciences (7 on the program), IQVIA Laboratories (1 on the program), Sygnature Discovery (3 on the program). 49 of them have their own page in this guide. As of Oct 9, 2026.

All 1,867 organizations at SfN 2026 →

Showing 1–7 of 70 organizations

Organization	SfN 2026 Attendance
Suven Life Sciences Hyderabad, India
suven.com Contract research and service companies Indian company offering drug discovery and development support services, with its own central nervous system drug pipeline.	Booth Exhibiting at Booth 423 Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm Poster Sat Nov 14 1–5pm Part of Session PSTR004: Schizophrenia Therapeutics: Animal and Human Studies SUVN-M8036, a multimodal receptor antagonist that exhibits antipsychotic and anti-aggressive like effects in animal models WCC Halls A-C · Board N7 Poster Sat Nov 14 1–5pm Part of Session PSTR034: Cross-Disorder Variations in Cognition and Brain Architecture Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SUVN-I6107, a Pure M1 Positive Allosteric Modulator: Results from a First-in-Human Study in Healthy Subjects WCC Halls A-C · Board JJ10 Poster Sat Nov 14 1–5pm Part of Session PSTR034: Cross-Disorder Variations in Cognition and Brain Architecture SUVN-L1101142, a Novel Muscarinic M4 Positive Allosteric Modulator, for the Treatment of Alzheimer’s Disease and Schizophrenia WCC Halls A-C · Board JJ11 Poster Mon Nov 16 1–5pm Part of Session PSTR192: Sleep Regulation: Anatomy, Pharmacology, Behavior Efficacy and Safety of Samelisant, an H3 Receptor Inverse Agonist, for the Treatment of Narcolepsy with or without Cataplexy: A Phase 3 Study WCC Halls A-C · Board EE18 Poster Tue Nov 17 8am–noon Part of Session PSTR222: Parkinson's Disease: Therapeutic Strategies in Preclinical Models Efficacy of SUVN-N9503012, a Selective 5-HT1A Receptor Partial Agonist, Intended for the Treatment of L-Dopa induced dyskinesia WCC Halls A-C · Board W18 Poster Tue Nov 17 8am–noon Part of Session PSTR241: Mood Disorders: Treatment and Drug Discovery Ropanicant (SUVN-911), an α4β2 nAChR Antagonist: A Phase-2b, Randomized, Double-blind, Placebo-controlled, Parallel-group Study, Evaluating the Efficacy and Safety of Ropanicant in Patients with Major Depressive Disorder WCC Halls A-C · Board II27 Poster Tue Nov 17 1–5pm Part of Session PSTR262: Alzheimer's Disease Therapeutic Strategies: Other Masupirdine (5-HT 6 Receptor Antagonist): Baseline Characteristics from a Phase 3 Study in Alzheimer’s Dementia with Agitation WCC Halls A-C · Board V22
IQVIA Laboratories Kuopio, Finland
labs.iqvia.com Contract research and service companies Central laboratory and bioanalytical services provider for clinical trials, part of IQVIA.	Booth Exhibiting at Booth 1407 Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm Poster Sat Nov 14 1–5pm Part of Session PSTR015: Trigeminal Circuits: Migraine, Headache, Orofacial, and Ocular Characterization of chemically-induced migraine models in mice using behavioral and functional imaging readouts WCC Halls A-C · Board Y5 Poster Sun Nov 15 8am–noon Part of Session PSTR049: Alzheimer's Disease: Blood Flow and Metabolism Neurovascular changes in DOCA-hypertension model in mice WCC Halls A-C · Board U13 Talk Mon Nov 16 11:30am–noon Part of Session PROT07: Powering Neuroscience Drug Discovery Speaker Grand Product Theater – Aisle 1400 Poster Wed Nov 18 1–5pm Part of Session PSTR345: Seizure Networks, Circuit Dynamics, Detection, and Post-Seizure States Low-mortality chronic epilepsy model using fractionated kainic acid dosing and seizure imaging with functional ultrasound WCC Halls A-C · Board O3 Poster Wed Nov 18 1–5pm Part of Session PSTR347: Neuro-Oncology: Therapeutics, Diagnostics, and Clinical Outcomes Contrast-enhanced MRI as a tool for monitoring blood-brain barrier leakage in an orthotopic U-87 MG rat model WCC Halls A-C · Board S2
Sygnature Discovery Nottingham, UK
sygnaturediscovery.com Contract research and service companies UK integrated drug discovery contract research organization, including neuroscience programs.	Booth Exhibiting at Booth 1134 Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm Poster Sat Nov 14 1–5pm Part of Session PSTR035: Pharmacological Modulation of Learning and Memory: Receptor Mechanisms, Disease Models, and Therapeutic Candidates The importance of habituation in scopolamine induced cognitive impairment assessed in the novel object recognition task WCC Halls A-C · Board KK1 Poster Sat Nov 14 1–5pm Part of Session PSTR039: Gene, Protein, or Cell Based Approaches High-Throughput Screening Platform and Orthogonal Assays for Apelin Receptor Discovery WCC Halls A-C · Board KK61 Poster Sun Nov 15 8am–noon Part of Session PSTR043: Neurotransmitter Transport and Degradation A Multi‑Platform Strategy for Functional Characterisation of EAAT2 WCC Halls A-C · Board I5 Poster Mon Nov 16 1–5pm Part of Session PSTR166: Other Ion Channels Electrophysiological Characterization of Human Piezo1 Channels Expressed in HEK Cells Using the SyncroPatch 384i and FLIPR Assays WCC Halls A-C · Board H3 Poster Wed Nov 18 1–5pm Part of Session PSTR354: Neuroinflammation: Disease Mechanisms Serial time course assessment of lipopolysaccharide-induced neuroinflammation in the rat hippocampus using cerebral open flow microperfusion WCC Halls A-C · Board X9
Transpharmation Fergus, Canada
transpharmation.com Contract research and service companies Preclinical neuroscience contract research organization offering translational drug discovery studies.	Booth Exhibiting at Booth 717 Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm Poster Sun Nov 15 1–5pm Part of Session LBP011: H.05. Mood Disorders APPLICATION OF DRUG DISCRIMINATION TECHNIQUES TO THE CHARACTERISATION OF NOVEL NON-PSYCHEDELIC 5-HT2A RECEPTOR AGONISTS WCC Halls A-C · Board B54 Poster Sun Nov 15 1–5pm Part of Session LBP011: H.05. Mood Disorders GLP-1R agonist and dual GIPR/GLP-1R Agonism Show Antidepressant-Like Activity in a Translational Mouse Model of Depression WCC Halls A-C · Board B55 Poster Sun Nov 15 1–5pm Part of Session PSTR087: Alzheimer's Disease: Abeta Mechanisms Longitudinal Characterization of Sleep and EEG in the ARTE10 Mouse Model WCC Halls A-C · Board S2 Poster Wed Nov 18 1–5pm Part of Session LBP082: I.04. Executive Functions Pharmacological and Phenotypic Validation of the Differential Reinforcement of Low Rates Task for Assessing Impulsive Action in Mice WCC Halls A-C · Board B43 Poster Wed Nov 18 1–5pm Part of Session PSTR375: Drug Discovery and Novel Therapeutics for Substance Use Disorders 5-MeO-DMT Selectively Attenuates Oral Ethanol Self-Administration in Male and Female Wistar Rats WCC Halls A-C · Board KK16
WuXi AppTec Qidong, Nantong, China
wuxiapptec.com Contract research and service companies Contract research, development and manufacturing organization serving drug developers worldwide.	Booth Exhibiting at Booth 706 Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm Poster Sat Nov 14 1–5pm Part of Session PSTR004: Schizophrenia Therapeutics: Animal and Human Studies Antipsychotic Efficacies and Side Effects Evaluation and Head-To-Head Comparison of Xanomeline and KarXT in Preclinical Rodent Models of Schizophrenia WCC Halls A-C · Board N6 Poster Tue Nov 17 8am–noon Part of Session PSTR219: Metabolic and Neural Changes Across Brain Aging: Experimental Models AAV‑driven hepatic IL‑11 overexpression as a rapid mouse model of aging WCC Halls A-C · Board Web Only Poster Tue Nov 17 1–5pm Part of Session PSTR263: Parkinson's Disease: Alpha-Synuclein siRNA Targeting SNCA Alleviates Pathology and Motor Deficits in a Rat Parkinson’s Model Induced by AAV-α-Syn/PFF WCC Halls A-C · Board W20 Poster Wed Nov 18 8am–noon Part of Session PSTR304: Alzheimer's Disease: Therapeutic Strategies: Amyloidosis Models Differential Induction of ARIA-like Pathologies by Anti-Aβ Immunotherapies in 5XFAD Mice: A Comprehensive Analysis of 12-Weeks Dosing with Clinical-Stage Antibodies WCC Halls A-C · Board U26 Poster Wed Nov 18 1–5pm Part of Session PSTR375: Drug Discovery and Novel Therapeutics for Substance Use Disorders Semaglutide Demonstrated Differentiated Efficacies on Preclinical Models of Alcohol and Substance Use Disorders in Rats WCC Halls A-C · Board KK7
Naason Science Cheongju, South Korea
naasonscience.com Contract research and service companies South Korean preclinical contract research organization offering disease models and drug development studies.	Booth Exhibiting at Booth 910 Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm Poster Sun Nov 15 8am–noon Part of Session LBP002: C.02. Alzheimer's Disease and Other Dementias Longitudinal MRI Characterization of Aβ Antibody-Associated ARIA-E and ARIA-H in 5xFAD and ARET10 Mice WCC Halls A-C · Board B34 Poster Mon Nov 16 8am–noon Part of Session PSTR145: Sleep: Behavior in Animal Models Home Cage Analysis Enables Scalable and Cost-Effective Wakefulness Assessment for Preclinical Screening of Sleep Therapeutics WCC Halls A-C · Board EE16 Poster Wed Nov 18 8am–noon Part of Session PSTR314: Inflammatory Pain and Itch Peripheral Sensitization, Neuroinflammation, and Central Pain Dysregulation in Rodent Models of Endometriosis: A Comparative Induction Study WCC Halls A-C · Board BB19 Poster Wed Nov 18 1–5pm Part of Session PSTR348: Brain Health and Cognition: Mechanisms and Biomarkers Elevated Serum Neurofilament Light Chain in Canine Cognitive Dysfunction Is Independent of Peripheral Neuroinflammatory Cytokine Profiles WCC Halls A-C · Board T13
PsychoGenics Paramus, NJ
psychogenics.com Contract research and service companies Preclinical contract research organization for central nervous system drug discovery, using behavioral and translational models.	Booth Exhibiting at Booth 1608 Sun, Nov 159:30am–5:00pmMon, Nov 169:30am–5:00pmTue, Nov 179:30am–5:00pmWed, Nov 189:30am–5:00pm Poster Sat Nov 14 1–5pm Part of Session PSTR015: Trigeminal Circuits: Migraine, Headache, Orofacial, and Ocular Effect of acute isosorbide dinitrate (ISDN) administration on plasma and brain concentrations of therapeutic compounds in rats WCC Halls A-C · Board Y10 Poster Mon Nov 16 1–5pm Part of Session PSTR179: Non-Opioid Treatments for Persistent Pain Pharmacological characterization of rat models of chemotherapy-induced peripheral neuropathy WCC Halls A-C · Board X7 Poster Mon Nov 16 1–5pm Part of Session PSTR179: Non-Opioid Treatments for Persistent Pain In vivo PK, side effect profile, and analgesic efficacy of buprenorphine and ketorolac in male and female rats WCC Halls A-C · Board X8 Poster Tue Nov 17 8am–noon Part of Session PSTR226: Pain: Spinal Circuits Assessment of Duloxetine Efficacy in the Rat Spinal Nerve Ligation (SNL) Model on Wide Dynamic Range (WDR) Neuron Activity Using In vivo Electrophysiology WCC Halls A-C · Board Z24

Instantly find 20 buyers from contract research and service companies

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction

Instantly find 20 buyers from contract research and service companies

Browse SfN 2026 by